A third category, defined as triple-negative (ALK−, DUSP22−, and TP63−), harbors the remaining 62% of ALK− ALCL cases and has a 5-year OS rate of 42% (67). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.